The Effect of Free Gingival Graft on Root Closure
Launched by BERCESTE GULER · Oct 28, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a surgical technique called a free gingival graft, which is used to help improve gum health by increasing the width of the gum tissue around teeth that have receded. This procedure aims to close gaps and reduce sensitivity in the gums, particularly in the front lower teeth where patients often experience these issues. The trial will involve 40 participants who will be divided into two groups based on where the graft is placed, either above or below the gum line, to see which approach works better for closing these gaps.
To be eligible for the trial, participants must be between 18 and 99 years old, have at least one tooth with gum recession in the front lower area, and should not have any major health issues or recent gum surgeries. Participants can expect to receive the surgical treatment and will be monitored to see how well the graft helps their gum condition. This trial is currently recruiting, and it’s a great opportunity for those struggling with gum recession to possibly improve their oral health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. 18-99 years old
- • 2. The patient does not have any systemic disease
- • 3. Presence of at least one tooth with gingival recession in the mandibular anterior region
- • 4. Excessive dentin sensitivity and impaired esthetics associated with recession
- • 5. Identification of the enamel-cementum boundary in the shrinkage region
- • 6. The tooth is alive and there are no irregularities, grooves, caries and restorations in the area to be treated.
- • 7. No periodontal surgical treatment in the relevant areas in the last 24 months
- • 8. Presence of adequate keratinized and attached gingiva in the donor area
- Exclusion Criteria:
- • 1. Being outside the specified age range
- • 2. Any contraindication for systematic periodontal surgery
- • 3. Failure to define the enamel-cementum boundary in the withdrawal region
- • 4. Presence of caries, restoration, root concavity in the area to be treated
- • 5. Patients who smoke more than 10 cigarettes per day
- • 6. Patients who use drugs that suppress the immune system or impair recovery
- • 7. Patients using drugs that impair bleeding
- • 8. Insufficient keratinized and attached gingiva in the donor area
About Berceste Guler
Berceste Guler is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative study designs and rigorous scientific methodologies. With a focus on collaboration and integrity, Berceste Guler fosters partnerships with research institutions and healthcare professionals to facilitate the development of cutting-edge therapies. The organization emphasizes ethical considerations and regulatory compliance, ensuring that all trials prioritize participant safety and data integrity. Through its comprehensive approach to clinical trial management, Berceste Guler aims to contribute significantly to the global healthcare landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kütahya, , Turkey
Patients applied
Trial Officials
Berceste Güler
Study Director
Kütahya Health Sciences University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials